Cargando…
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: To evaluate the effect of recombinant erythropoietin on hospitalised COVID-19 patients. TRIAL DESIGN: Concealed, randomized, single-blinded, phase 2 controlled clinical trial with two arm parallel-group design of 20 patients allocated with 1:1 ratio and using the placebo in the control g...
Autores principales: | Samimagham, Hamid Reza, Azad, Mehdi Hassani, Hooshyar, Dariush, Haddad, Maryam, Arabi, Mohsen, KazemiJahromi, Mitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258474/ https://www.ncbi.nlm.nih.gov/pubmed/34229729 http://dx.doi.org/10.1186/s13063-021-05363-w |
Ejemplares similares
-
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
por: Samimagham, Hamid Reza, et al.
Publicado: (2020) -
The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
por: Rahimi, Arash, et al.
Publicado: (2021) -
Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012) -
Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution
por: Aachmann-Andersen, Niels Jacob, et al.
Publicado: (2014) -
The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997)